These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44 related articles for article (PubMed ID: 2509645)
1. The in vitro activity of tigemonam: a comparison with other antimicrobial agents. Andrews JM; Wise R J Chemother; 1989 May; 1 Suppl 2():5-12. PubMed ID: 2509645 [TBL] [Abstract][Full Text] [Related]
2. The In Vitro Activity of Tigemonam: a Comparison with Other Antimicrobial Agents. Andrews JM; Wise R J Chemother; 1989 May; 1(sup2):5-12. PubMed ID: 27416143 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of tigemonam against urinary tract pathogens. Garcia-Rodriguez JA; Garcia-Sanchez JE J Chemother; 1989 May; 1 Suppl 2():28-31. PubMed ID: 2809699 [TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity in vitro of tigemonam, a new oral monobactam. Schito GC; Debbia E; Bandelloni R; Paglia P; Pesce A J Chemother; 1989 May; 1 Suppl 2():41-4. PubMed ID: 2809702 [TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of tigemonam, a novel oral monobactam. Tanaka SK; Summerill RA; Minassian BF; Bush K; Visnic DA; Bonner DP; Sykes RB Antimicrob Agents Chemother; 1987 Feb; 31(2):219-25. PubMed ID: 3105448 [TBL] [Abstract][Full Text] [Related]
6. Comparative in-vitro activity of tigemonam, a new monobactam. Rylander M; Gezelius L; Norrby SR J Antimicrob Chemother; 1988 Sep; 22(3):307-13. PubMed ID: 3182428 [TBL] [Abstract][Full Text] [Related]
7. In vitro activity of tigemonam against multiresistant nosocomial Enterobacteriaceae. Giamarellou H; Pephanis A; Grammatikou M; Avlamis A; Papoulias G J Chemother; 1989 May; 1 Suppl 2():32-5. PubMed ID: 2809700 [TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity of tigemonam dicholate (SQ 30836) and interaction with beta-lactamases of gram-negative bacteria. Raimondi A; Cocuzza CE J Chemother; 1989 May; 1 Suppl 2():13-21. PubMed ID: 2809698 [TBL] [Abstract][Full Text] [Related]
9. Tigemonam, an oral monobactam. Chin NX; Neu HC Antimicrob Agents Chemother; 1988 Jan; 32(1):84-91. PubMed ID: 3279906 [TBL] [Abstract][Full Text] [Related]
10. In vitro studies of tigemonam: a comparison of the minimum inhibitory and minimum bactericidal concentrations (MIC vs MBC). Gobernado M; Cantón E J Chemother; 1989 May; 1 Suppl 2():36-40. PubMed ID: 2809701 [TBL] [Abstract][Full Text] [Related]
11. Tigemonam activity against clinical isolates of Enterobacteriaceae and Enterobacteriaceae with known mechanisms of resistance to beta-lactam antibiotics. Nélet F; Gutmann L; Kitzis MD; Acar JF J Antimicrob Chemother; 1989 Aug; 24(2):173-81. PubMed ID: 2676940 [TBL] [Abstract][Full Text] [Related]
12. Bactericidal activity of tigemonam, alone and in combination with gentamicin. Shah PM; Gänger-Farshid G; Mulert R; Stille W J Chemother; 1989 May; 1 Suppl 2():45-8. PubMed ID: 2809703 [TBL] [Abstract][Full Text] [Related]
13. In Vitro Activity of Tigemonam Against Urinary Tract Pathogens. Garcia-Rodriguez JA; Garcia-Sanchez JE J Chemother; 1989 May; 1(sup2):28-31. PubMed ID: 27416146 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456 [TBL] [Abstract][Full Text] [Related]
15. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli]. Thabaut A; Meyran M; Huerre M Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity of ceftriaxone: a review. Cleeland R; Squires E Am J Med; 1984 Oct; 77(4C):3-11. PubMed ID: 6093515 [TBL] [Abstract][Full Text] [Related]
17. Comparative antimicrobial activity of ceftibuten against multiply-resistant microorganisms from Belgium. Verbist L; Jacobs J; Hens K Diagn Microbiol Infect Dis; 1991; 14(1):53-61. PubMed ID: 1901535 [TBL] [Abstract][Full Text] [Related]
18. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations. Jones RN; Huynh HK; Biedenbach DJ; Fritsche TR; Sader HS J Antimicrob Chemother; 2004 Jul; 54(1):144-54. PubMed ID: 15190031 [TBL] [Abstract][Full Text] [Related]
19. In vitro antimicrobial activity of tigemonam, a new orally administered monobactam. Fuchs PC; Jones RN; Barry AL Antimicrob Agents Chemother; 1988 Mar; 32(3):346-9. PubMed ID: 3259122 [TBL] [Abstract][Full Text] [Related]
20. The new monobactams: chemistry and biology. Sykes RB; Koster WH; Bonner DP J Clin Pharmacol; 1988 Feb; 28(2):113-9. PubMed ID: 3360965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]